GlobeNewswire - News from SwedenContains the last 20 releasesuuid:8827fcb9-fcf6-4519-a6b6-32c51d8b3590;id=133492021-03-02T16:02:29Znewsdesk@globenewswire.com (NewsDesk)http://www.yebxqs.cn/LegacyRss?Length=4newsdesk@globenewswire.comhttp://www.yebxqs.cn/news-release/2021/03/02/2185562/0/en/Karolinska-Development-s-portfolio-company-OssDsign-announces-a-fully-guaranteed-rights-issue-and-launches-new-corporate-strategy.htmlKarolinska Development’s portfolio company OssDsign announces a fully guaranteed rights issue and launches new corporate strategy2021-03-02T16:02:29Z2021-03-03T01:57:20ZSTOCKHOLM, SWEDEN – March 2, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign has decided to carry out a fully guaranteed rights issue of SEK 240 million in combination with overallotment options of up to approximately SEK 30 million – a total of approximately SEK 270 million. The purpose of the financing is, among other things, to accelerate the company's development through the new strategy program ASCENT25. ]]>2185562enGlobeNewswire Inc.Karolinska Development AB (publ)Tue, 02 Mar 2021 16:02 GMTCompany Announcementhttp://www.yebxqs.cn/news-release/2021/03/02/2185562/0/sv/Karolinska-Developments-portf%C3%B6ljbolag-OssDsign-genomf%C3%B6r-en-fullt-garanterad-f%C3%B6retr%C3%A4desemission-och-lanserar-ny-bolagsstrategi.htmlKarolinska Developments portf?ljbolag OssDsign genomf?r en fullt garanterad f?retr?desemission och lanserar ny bolagsstrategi2021-03-02T16:02:29Z2021-03-03T01:57:20ZSTOCKHOLM, SVERIGE 2 mars 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen i portf?ljbolaget OssDsign har beslutat att genomf?ra en fullt garanterad f?retr?desemission om SEK 240 miljoner i kombination med ?vertilldelningsoptioner om upp till cirka SEK 30 miljoner –?totalt cirka SEK 270 miljoner. Syftet med finansieringen ?r bland annat att acclerera bolagets utveckling genom det nya strategiprogrammet ASCENT25. ]]>2185562svGlobeNewswire Inc.Karolinska Development AB (publ)Tue, 02 Mar 2021 16:02 GMTCompany Announcementhttp://www.yebxqs.cn/news-release/2021/03/02/2185527/0/en/USD-TENDER-OPERATION-ANNOUNCEMENT.htmlUSD TENDER OPERATION ANNOUNCEMENT2021-03-02T15:20:00Z2021-03-03T01:57:20ZStockholm, 2021-03-02]]>2185527enGlobeNewswire Inc.Sveriges RiksbankTue, 02 Mar 2021 15:20 GMTBond Market Newshttp://www.yebxqs.cn/news-release/2021/03/02/2185370/0/en/LIDDS-enters-R-D-agreement-with-potential-exclusive-global-product-license-option.htmlLIDDS enters R&D agreement with potential exclusive, global product license option2021-03-02T13:50:00Z2021-03-03T01:57:20ZUPPSALA, SWEDEN – LIDDS AB (publ) announced today that an agreement has been signed with Johnson & Johnson Enterprise Innovation Inc. to develop an oncology product based on the NanoZolid? technology for an undisclosed indication. ]]>2185370enGlobeNewswire Inc.LIDDS ABTue, 02 Mar 2021 13:50 GMTCompany AnnouncementEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/02/2185215/0/en/Systemair-s-Interim-Report-for-the-third-quarter-will-be-presented-on-March-11.html Systemair's Interim Report for the third quarter will be presented on March 112021-03-02T13:00:00Z2021-03-03T01:57:20ZPress Release, 2 March 2021]]>2185215enGlobeNewswire Inc.Systemair ABTue, 02 Mar 2021 13:00 GMTRegulatory informationEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/02/2185215/0/sv/Systemairs-rapport-f%C3%B6r-det-tredje-kvartalet-presenteras-den-11-mars.html Systemairs rapport f?r det tredje kvartalet presenteras den 11 mars2021-03-02T13:00:00Z2021-03-03T01:57:20ZPressmeddelande 2 mars 2021]]>2185215svGlobeNewswire Inc.Systemair ABTue, 02 Mar 2021 13:00 GMTRegulatory informationEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/02/2184970/0/en/Result-of-Riksbank-reversed-auctions-SEK-Kommuninvest-Bonds.htmlResult of Riksbank reversed auctions SEK Kommuninvest Bonds2021-03-02T10:10:00Z2021-03-03T01:57:20Z ]]>2184970enGlobeNewswire Inc.Sveriges RiksbankTue, 02 Mar 2021 10:10 GMTBonds Market Informationhttp://www.yebxqs.cn/news-release/2021/03/02/2184926/0/en/RESULT-OF-RIKSBANK-CERTIFICATE-SALE.htmlRESULT OF RIKSBANK CERTIFICATE SALE2021-03-02T09:15:00Z2021-03-03T01:57:20Z2184926enGlobeNewswire Inc.Sveriges RiksbankTue, 02 Mar 2021 09:15 GMTBonds Market Informationhttp://www.yebxqs.cn/news-release/2021/03/02/2184904/0/en/CONDITIONS-FOR-SALE-OF-RIKSBANK-CERTIFICATES.htmlCONDITIONS FOR SALE OF RIKSBANK CERTIFICATES2021-03-02T08:30:00Z2021-03-03T01:57:20ZStockholm, 2021-03-02]]>2184904enGlobeNewswire Inc.Sveriges RiksbankTue, 02 Mar 2021 08:30 GMTBond Market NewsEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/01/2184784/0/en/Kvalitena-publicerar-bokslutskommunik%C3%A9-2020.htmlKvalitena publicerar bokslutskommuniké 20202021-03-01T23:01:31Z2021-03-03T01:57:20ZKvalitena publicerar bokslutskommuniké f?r 2020.]]>2184784enGlobeNewswire Inc.Kvalitena ABMon, 01 Mar 2021 23:01 GMTEarnings Releases and Operating ResultsEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/01/2184495/0/en/CONDITIONS-FOR-THE-RIKSBANK-S-PURCHASES-OF-COMMERCIAL-PAPER.htmlCONDITIONS FOR THE RIKSBANK′S PURCHASES OF COMMERCIAL PAPER2021-03-01T15:20:00Z2021-03-03T01:57:20ZStockholm, 2021-03-01]]>2184495enGlobeNewswire Inc.Sveriges RiksbankMon, 01 Mar 2021 15:20 GMTBonds Market Informationhttp://www.yebxqs.cn/news-release/2021/03/01/2184139/0/en/Karolinska-Development-appoints-Per-Aniansson-as-CFO-and-Investment-Director.htmlKarolinska Development appoints Per Aniansson as CFO and Investment Director2021-03-01T12:13:09Z2021-03-03T01:57:20Z STOCKHOLM, SWEDEN – March 1, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that Per Aniansson has been appointed as new CFO and Investment Director. He has extensive experience in investments, business development and financing of high-growth companies in the life science industry. Per Aniansson takes up the position on March 7 and will initially work part-time (50%) in the company. He replaces Fredrik J?rrsten, who has chosen to move on to a leading position within another life science company.]]>2184139enGlobeNewswire Inc.Karolinska Development AB (publ)Mon, 01 Mar 2021 12:13 GMTDirectors and OfficersEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/01/2184139/0/sv/Karolinska-Development-utser-Per-Aniansson-till-ny-finansdirekt%C3%B6r-och-Investment-Director.htmlKarolinska Development utser Per Aniansson till ny finansdirekt?r och Investment Director2021-03-01T12:13:09Z2021-03-03T01:57:20ZSTOCKHOLM, SVERIGE 1 mars 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att Per Aniansson har utsetts till ny finansdirekt?r och Investment Director. Han har omfattande erfarenhet av investeringsverksamhet, aff?rsutveckling och finansiering av tillv?xtbolag inom life science-industrin. Per Aniansson tilltr?der positionen den 7 mars och kommer inledningsvis att arbeta deltid (50%) i bolaget. Han ers?tter Fredrik J?rrsten som valt att g? vidare till en ledande befattning inom ett annat life science-f?retag. ? ]]>2184139svGlobeNewswire Inc.Karolinska Development AB (publ)Mon, 01 Mar 2021 12:13 GMTDirectors and OfficersEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/01/2183980/0/en/RESULT-OF-SEK-CREDIT-OPERATION.htmlRESULT OF SEK CREDIT OPERATION2021-03-01T10:45:00Z2021-03-03T01:57:20Z2183980enGlobeNewswire Inc.Sveriges RiksbankMon, 01 Mar 2021 10:45 GMTBond Market NewsEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/01/2183928/0/en/SEK-CREDIT-OPERATION-ANNOUNCEMENT.htmlSEK CREDIT OPERATION ANNOUNCEMENT2021-03-01T09:30:00Z2021-03-03T01:57:20ZStockholm, 2021-03-01]]>2183928enGlobeNewswire Inc.Sveriges RiksbankMon, 01 Mar 2021 09:30 GMTBonds Market Informationhttp://www.yebxqs.cn/news-release/2021/03/01/2183909/0/en/Net-asset-value-as-per-February-28-2021.htmlNet asset value as per February 28, 20212021-03-01T09:00:00Z2021-03-03T01:57:20ZOn February 28, 2021, net asset value was SEK 299 per share. ]]>2183909enGlobeNewswire Inc.Industriv?rden, ABMon, 01 Mar 2021 09:00 GMTNet Asset Valuehttp://www.yebxqs.cn/news-release/2021/03/01/2183909/0/sv/Substansv%C3%A4rdet-per-den-28-februari-2021.htmlSubstansv?rdet per den 28 februari 20212021-03-01T09:00:00Z2021-03-03T01:57:20ZDen 28 februari 2021 var substansv?rdet 299 kronor per aktie. ]]>2183909svGlobeNewswire Inc.Industriv?rden, ABMon, 01 Mar 2021 09:00 GMTNet Asset Valuehttp://www.yebxqs.cn/news-release/2021/03/01/2183878/0/sv/Hexatronic-f%C3%B6rv%C3%A4rvar-75-av-det-tyska-FTTH-kompetenscentret-TK-KONTOR-FREITAG-GmbH.htmlHexatronic f?rv?rvar 75% av det tyska FTTH-kompetenscentret TK-KONTOR-FREITAG GmbH2021-03-01T07:30:00Z2021-03-03T01:57:20ZHexatronic Group AB (publ) 556168-6360]]>2183878svGlobeNewswire Inc.Hexatronic Group ABMon, 01 Mar 2021 07:30 GMTRegulatory informationMergers and AcquisitionsEuropean Regulatory NewshexatronicTK-Kontor-FreitagFTTH#hexatronicftthTK-Kontor-Freitaghttp://www.yebxqs.cn/news-release/2021/03/01/2183878/0/en/Hexatronic-to-acquire-75-of-the-German-FTTH-competence-centre-TK-KONTOR-FREITAG-GmbH.htmlHexatronic to acquire 75% of the German FTTH competence centre TK-KONTOR-FREITAG GmbH2021-03-01T07:30:00Z2021-03-03T01:57:20ZHexatronic Group AB (publ) 556168-6360]]>2183878enGlobeNewswire Inc.Hexatronic Group ABMon, 01 Mar 2021 07:30 GMTRegulatory informationMergers and AcquisitionsEuropean Regulatory NewshexatronicTK-Kontor-FreitagFTTH#hexatronicftthTK-Kontor-Freitaghttp://www.yebxqs.cn/news-release/2021/03/01/2183865/0/sv/Immunicum-AB-publ-meddelar-att-Jeroen-Rovers-har-utsetts-till-medicinsk-chef.htmlImmunicum AB (publ) meddelar att Jeroen Rovers har utsetts till medicinsk chef2021-03-01T07:00:00Z2021-03-03T01:57:20ZPressmeddelande]]>2183865svGlobeNewswire Inc.Immunicum ABMon, 01 Mar 2021 07:00 GMTDirectors and OfficersEuropean Regulatory NewsChiefMedicalOfficerImmunicumimmuno-oncologyLeidenbiotechnologyswedenChiefMedicalOfficerbiotechnologyLeidenswedenImmunicumimmuno-oncology粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号